| Tuberculosis |
0 |
0.65 |
| Sleep Disorders |
0 |
0.64 |
| Non-Small Cell Lung Cancer |
0 |
0.59 |
| Biologic Therapy |
0 |
0.53 |
| Lung Cancer |
0 |
0.53 |
| Select Sleep Disorders |
0 |
0.53 |
| Lung |
0 |
0.45 |
| Small Cell Lung Cancer |
0 |
0.39 |
| Transplantation |
0 |
0.36 |
| Sleep |
0 |
0.31 |
| ADHD |
0 |
0.3 |
| HIV Infection |
0 |
0.29 |
| Cardiac Arrest |
0 |
0.27 |
| Gamma aminobutyric acid |
0 |
0.27 |
| Genomic Medicine |
0 |
0.27 |
| Toxicology |
0 |
0.26 |
| Organ Transplantation |
0 |
0.25 |
| Epidermal Growth Factor Receptor |
0 |
0.22 |
| Acute Pain |
0 |
0.2 |
| Neoadjuvant Therapy |
0 |
0.2 |
| Cancer |
0 |
0.18 |
| Chemotherapy |
0 |
0.18 |
| Clinical Guidelines |
0 |
0.18 |
| Hypersomnia |
0 |
0.18 |
| Thorax |
0 |
0.18 |
| Grant |
0 |
0.13 |
| Hospital |
0 |
0.13 |
| Narcolepsy |
0 |
0.13 |
| Receptors |
0 |
0.13 |
| Therapeutic Hypothermia |
0 |
0.13 |
| Benzodiazepines |
0 |
0.09 |
| Blood |
0 |
0.09 |
| Brain |
0 |
0.09 |
| Europe |
0 |
0.09 |
| Fever |
0 |
0.09 |
| Food and Drug Administration (FDA) |
0 |
0.09 |
| Hypothermia |
0 |
0.09 |
| Immunotherapy |
0 |
0.09 |
| Pain Management |
0 |
0.09 |
| Platinum |
0 |
0.09 |
| Tumor |
0 |
0.09 |
| Organ Procurement and Transplantation Network |
0 |
0.08 |
| Bone Marrow |
0 |
0.06 |
| Disaster Medicine |
0 |
0.05 |
| Influenza |
0 |
0.05 |
| Adenocarcinoma |
0 |
0.04 |
| Adherence |
0 |
0.04 |
| Anesthesia |
0 |
0.04 |
| Anticoagulation Therapy |
0 |
0.04 |
| Bone |
0 |
0.04 |
| Cataplexy |
0 |
0.04 |
| Child |
0 |
0.04 |
| Drug Interaction |
0 |
0.04 |
| Drug-Resistant Tuberculosis |
0 |
0.04 |
| HIV Testing |
0 |
0.04 |
| Intensivists |
0 |
0.04 |
| Neurotransmitters |
0 |
0.04 |
| Organ Procurement |
0 |
0.04 |
| Professional Development |
0 |
0.04 |
| Refractory |
0 |
0.04 |
| Resection |
0 |
0.04 |
| Resuscitation |
0 |
0.04 |
| Surgery |
0 |
0.04 |
| Waiting List |
0 |
0.04 |